Barely Significant
← all excerpts

The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.

Int J Mol Sci · 2024 · PMC11049849 · PMID 38673979

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

a strong trendp < 0.06so close (0.05 < p ≤ 0.1)
Similarly, ex vivo samples from IRL201805Res patients revealed a strong trend ( p < 0.06) at 72 h for greater intracellular expression of IDO when compared with Pbo at the same time-point.

also in 1,853 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.